Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020. (10th July 2021)
- Record Type:
- Journal Article
- Title:
- Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020. (10th July 2021)
- Main Title:
- Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
- Authors:
- Sullivan, Patrick Sean
Siegler, Aaron J
Shioda, Kayoko
Hall, Eric W
Bradley, Heather
Sanchez, Travis
Luisi, Nicole
Valentine-Graves, Mariah
Nelson, Kristin N
Fahimi, Mansour
Kamali, Amanda
Sailey, Charles
Lopman, Benjamin A - Abstract:
- Abstract: Background: Reported coronavirus disease 2019 (COVID-19) cases underestimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We conducted a national probability survey of US households to estimate cumulative incidence adjusted for antibody waning. Methods: From August–December 2020 a random sample of US addresses were mailed a survey and self-collected nasal swabs and dried blood spot cards. One adult household member completed the survey and mail specimens for viral detection and total (immunoglobulin [Ig] A, IgM, IgG) nucleocapsid antibody by a commercial, emergency use authorization–approved antigen capture assay. We estimated cumulative incidence of SARS-CoV-2 adjusted for waning antibodies and calculated reported fraction (RF) and infection fatality ratio (IFR). Differences in seropositivity among demographic, geographic, and clinical subgroups were explored. Results: Among 39 500 sampled households, 4654 respondents provided responses. Cumulative incidence adjusted for waning was 11.9% (95% credible interval [CrI], 10.5%–13.5%) as of 30 October 2020. We estimated 30 332 842 (CrI, 26 703 753–34 335 338) total infections in the US adult population by 30 October 2020. RF was 22.3% and IFR was 0.85% among adults. Black non-Hispanics (Prevalence ratio (PR) 2.2) and Hispanics (PR, 3.1) were more likely than White non-Hispanics to be seropositive. Conclusions: One in 8 US adults had been infected with SARS-CoV-2 by October 2020; however, fewAbstract: Background: Reported coronavirus disease 2019 (COVID-19) cases underestimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We conducted a national probability survey of US households to estimate cumulative incidence adjusted for antibody waning. Methods: From August–December 2020 a random sample of US addresses were mailed a survey and self-collected nasal swabs and dried blood spot cards. One adult household member completed the survey and mail specimens for viral detection and total (immunoglobulin [Ig] A, IgM, IgG) nucleocapsid antibody by a commercial, emergency use authorization–approved antigen capture assay. We estimated cumulative incidence of SARS-CoV-2 adjusted for waning antibodies and calculated reported fraction (RF) and infection fatality ratio (IFR). Differences in seropositivity among demographic, geographic, and clinical subgroups were explored. Results: Among 39 500 sampled households, 4654 respondents provided responses. Cumulative incidence adjusted for waning was 11.9% (95% credible interval [CrI], 10.5%–13.5%) as of 30 October 2020. We estimated 30 332 842 (CrI, 26 703 753–34 335 338) total infections in the US adult population by 30 October 2020. RF was 22.3% and IFR was 0.85% among adults. Black non-Hispanics (Prevalence ratio (PR) 2.2) and Hispanics (PR, 3.1) were more likely than White non-Hispanics to be seropositive. Conclusions: One in 8 US adults had been infected with SARS-CoV-2 by October 2020; however, few had been accounted for in public health reporting. The COVID-19 pandemic is likely substantially underestimated by reported cases. Disparities in COVID-19 by race observed among reported cases cannot be attributed to differential diagnosis or reporting of infections in population subgroups. Abstract : One in 8 US adults had been infected with severe acute respiratory syndrome coronavirus 2 by late October 2020; however, few had been accounted for in public health reporting. The scope of the coronavirus disease 2019 pandemic is likely substantially underestimated by reported cases. We conducted a national probability survey of US households to estimate the cumulative incidence adjusted for antibody waning. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 74:Number 7(2022)
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 74:Number 7(2022)
- Issue Display:
- Volume 74, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 74
- Issue:
- 7
- Issue Sort Value:
- 2022-0074-0007-0000
- Page Start:
- 1141
- Page End:
- 1150
- Publication Date:
- 2021-07-10
- Subjects:
- SARS-CoV-2 -- serology -- probability survey -- incidence -- viral detection
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/ciab626 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21258.xml